|  |  |  | | Advertisement |  | |  | | | Inside LI | Top |  | Inside Lab Invest2012 92: 1664-1665; 10.1038/labinvest.2012.165 Full Text |  | Editorials | Top |  | Beyond the RAAS: dissecting the antifibrotic effects of vitamin D analoguesKatarina Mirković and Martin H de Borst 2012 92: 1666-1669; 10.1038/labinvest.2012.150 Full Text |  |  |  | MDR-1, Bcl-xL, H. pylori, and Wnt/β-catenin signalling in the adult stomach: how much is too much?R John MacLeod 2012 92: 1670-1673; 10.1038/labinvest.2012.151 Full Text |  | Research Articles | Top |  | GENITOURINARY AND REPRODUCTIVE SYSTEMS | Impairment of podocyte function by diphtheria toxin—a new reversible proteinuria model in miceDiphtheria toxin (DTx)-induced transient kidney dysfunction is presented as a new reversible model of experimental podocyte injury. Treatment of mice with DTx leads to a transient and completely reversible proteinuria as a consequence of podocyte dysfunction that is morphologically characterized by foot process fusion and detachment from the glomerular basal membrane. Andreas Goldwich, Alexander Steinkasserer, André Gessner and Kerstin Amann 2012 92: 1674-1685; advance online publication, September 24, 2012; 10.1038/labinvest.2012.133 Abstract | Full Text |  |  |  | Maxacalcitol ameliorates tubulointerstitial fibrosis in obstructed kidneys by recruiting PPM1A/VDR complex to pSmad3Maxacalcitol (OCT), a vitamin D analog, ameliorates tubulointerstitial fibrosis in the obstructed kidney without suppressing renal renin. OCT attenuates pSmad3- dependent production of TGF-β1 by recruiting a complex of the vitamin D receptor and pSmad3 phosphatase, PPM1A. OCT therefore serves as an inhibitor of the Smad3/TGF-β1 cycle in fibrotic kidney disease. Kazunori Inoue, Isao Matsui, Takayuki Hamano, Naohiko Fujii, Akihiro Shimomura, Chikako Nakano, Yasuo Kusunoki, Yoshitsugu Takabatake, Michinori Hirata, Akira Nishiyama, Yoshiharu Tsubakihara, Yoshitaka Isaka and Hiromi Rakugi 2012 92: 1686-1697; advance online publication, August 27, 2012; 10.1038/labinvest.2012.107 Abstract | Full Text |  |  |  | The monocyte chemoattractant protein-1 (MCP-1)/CCR2 system is involved in peritoneal dialysis-related epithelial–mesenchymal transition of peritoneal mesothelial cellsEpithelial-mesenchymal transition (EMT) of peritoneal mesothelial cells influences development of peritoneal fibrosis (PF), a serious complication of peritoneal dialysis (PD). The monocyte chemoattractant protein-1/CCR2 system is shown to be directly involved in PD-related EMT, and extracellular matrix synthesis is mediated via TGF-β1, indicating therapeutic targets for prevention of PF. Sun Ha Lee, Hye-Young Kang, Kyung Sik Kim, Bo Young Nam, Jisun Paeng, Seonghun Kim, Jin Ji Li, Jung Tak Park, Dong Ki Kim, Seung Hyeok Han, Tae-Hyun Yoo and Shin-Wook Kang 2012 92: 1698-1711; advance online publication, September 24, 2012; 10.1038/labinvest.2012.132 Abstract | Full Text |  |  |  | HEPATIC AND PANCREATIC AND GASTROINTESTINAL SYSTEMS | Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosisLumican, a matrix proteoglycan involved in collagen fibril assembly, is upregulated in liver injury in response to TGF-β1, making it a therapeutic target for treatment of hepatic fibrosis. Lumican-null mice are protected from carbon tetrachloride-induced fibrosis by the impairment in collagen fibrillogenesis, increased matrix turnover, and an enhanced proliferative response. Anuradha Krishnan, Xia Li, WinstonWhei-Yang Kao, Kimberly Viker, Kim Butters, Howard Masuoka, Bruce Knudsen, Gregory Gores and Michael Charlton 2012 92: 1712-1725; advance online publication, September 24, 2012; 10.1038/labinvest.2012.121 Abstract | Full Text |  |  |  | Lack of hepatic c-Met and gp130 expression is associated with an impaired antibacterial response and higher lethality after bile duct ligationHepatocyte growth factor/c-Met and interleukin-6/gp130 control hepatic cytoprotective pathways and show promise as therapeutic strategies for liver failure. They are involved in the hepatic antibacterial and innate immune responses and control the acute-phase response, thus preventing sepsis and liver injury during cholestatic conditions. Arne Giebeler, Lars-Ove Brandenburg, Michaela Kaldenbach, Stephanie Erschfeld, Hermann Wasmuth, Christoph Wruck, Christian Trautwein and Konrad L Streetz 2012 92: 1726-1737; advance online publication, September 17, 2012; 10.1038/labinvest.2012.122 Abstract | Full Text |  |  |  | Salvianolic acid B lowers portal pressure in cirrhotic rats and attenuates contraction of rat hepatic stellate cells by inhibiting RhoA signaling pathwayContraction of hepatic stellate cells (HSCs) is critical for regulation of intrahepatic vascular resistance. Salvianolic acid B (Sal B), a potential candidate for the pharmacological treatment of portal hypertension, decreases portal pressure in cirrhotic livers. Mechanistically, Sal B reduces contraction of activated HSCs by inhibiting the RhoA/ROCK II signaling pathway. Hong Xu, Yang Zhou, Chao Lu, Jian Ping and Lie-Ming Xu 2012 92: 1738-1748; advance online publication, September 17, 2012; 10.1038/labinvest.2012.113 Abstract | Full Text |  |  |  | Lack of MMP10 exacerbates experimental colitis and promotes development of inflammation-associated colonic dysplasiaMatrix metalloproteinase MMP10, produced by infiltrating myeloid cells after colonic damage, plays a role in resolution of the disease. In the absence of this enzyme, colonic inflammation persists and eventually results in the development of dysplastic lesions. Thus, enhancing MMP10 expression may be a therapeutic strategy for promotion of mucosal healing. Felicitas L Koller, E Ashley Dozier, Ki Taek Nam, Mei Swee, Timothy P Birkland, William C Parks and Barbara Fingleton 2012 92: 1749-1759; advance online publication, October 8, 2012; 10.1038/labinvest.2012.141 Abstract | Full Text |  |  |  | ANGIOGENESIS, CARDIOVASCULAR AND PULMONARY SYSTEMS | Pulmonary imaging with a scanning acoustic microscope discriminates speed-of-sound and shows structural characteristics of diseaseTissue elasticity can be detected using a scanning acoustic microscope, whereby acoustic images are created measuring the speed of sound through tissues. This system discriminates between pulmonary tissue components and demonstrates distinct acoustic images of the lung; the images correspond well to those obtained from a conventional microscope. Katsutoshi Miura and Seiji Yamamoto 2012 92: 1760-1765; advance online publication, September 24, 2012; 10.1038/labinvest.2012.135 Abstract | Full Text |  |  |  | Impaired post-infarction cardiac remodeling in chronic kidney disease is due to excessive renin releaseThe renin-angiotensin system (RAS) has a critical role in the development of cardiorenal syndrome, the complex pathophysiological interactions between heart and kidney diseases. A novel animal model for cardiorenal syndrome suggests that nephrectomy exacerbates myocardial ischemia-induced left ventricular dysfunction, and that renin activity is responsible for adverse myocardial remodeling. Masahito Ogawa, Jun-ichi Suzuki, Kiyoshi Takayama, Takaaki Senbonmatsu, Yasunobu Hirata, Ryozo Nagai and Mitsuaki Isobe 2012 92: 1766-1776; advance online publication, September 17, 2012; 10.1038/labinvest.2012.136 Abstract | Full Text |  |  |  | BREAST, SKIN, SOFT TISSUE AND BONE | Nordihydroguaiaretic acid inhibition of NFATc1 suppresses osteoclastogenesis and arthritis bone destruction in ratsRecruitment of osteoclasts is observed at sites of bone destruction in rheumatoid arthritis (RA). Nordihydroguaiaretic acid (NDGA) is an ancient treatment now shown to suppress osteoclast differentiation through NFATc1, a key transcription factor for osteoclastogenesis. NDGA therefore holds promise as a therapeutic agent for amelioration of inflammatory bone destruction in RA. Yin-Ji Li, Akiko Kukita, Toshiyuki Watanabe, Toshio Takano, Pengfei Qu, Keisuke Sanematsu, Yuzo Ninomiya and Toshio Kukita 2012 92: 1777-1787; advance online publication, October 8, 2012; 10.1038/labinvest.2012.134 Abstract | Full Text |  |  |  | BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cellsLoss of cell surface glycoprotein T-cadherin has been implicated in cancer progression. Promoter hypermethylation and transcriptional repression of T-cadherin by the transcription factor BRN2 results in malignant transformation of melanoma cells, increasing invasion and migration. Regulation of T-cadherin could therefore be a focus of future melanoma therapies. Lisa Ellmann, Manjunath B Joshi, Therese J Resink, Anja K Bosserhoff and Silke Kuphal 2012 92: 1788-1800; advance online publication, October 15, 2012; 10.1038/labinvest.2012.140 Abstract | Full Text |  | Retraction | Top |  | Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodelingKejun Zhang, Dong Chen, Xuelong Jiao, Shaoyan Zhang, Xiangping Liu, Jingyu Cao, Liqun Wu and Dongsheng Wang 2012 92: 1801; advance online publication, November 19, 2012; 10.1038/labinvest.2012.138 Full Text |  | Corrigenda | Top |  | Complementary inhibition of cerebral aneurysm formation by eNOS and nNOSTomohiro Aoki, Masaki Nishimura, Hiroharu Kataoka, Ryota Ishibashi, Kazuhiko Nozaki and Susumu Miyamoto 2012 92: 1802; 10.1038/labinvest.2012.137 Full Text |  |  |  | TNF gene cluster deletion abolishes lipopolysaccharide-mediated sensitization of the neonatal brain to hypoxic ischemic insultGiles S Kendall, Mariya Hirstova, Sigrun Horn, Dimitra Dafou, Alejandro Acosta-Saltos, Beatriz Almolda, Virginia Zbarsky, Prakasham Rumajogee, Heike Heuer, Bernardo Castellano, Klaus Pfeffer, Sergei A Nedospasov, Donald M Peebles and Gennadij Raivich 2012 92: 1803; 10.1038/labinvest.2012.152 Full Text |  |  |  |  |  | | Advertisement |  | |  | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Laboratory Investigation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | |
No comments:
Post a Comment